Basic Neuroscience Related Content

Elif Engin, PhD, grew up in Ankara, Turkey, and earned her undergraduate and master’s degrees at Middle East Technical University (METU) in Ankara. She completed her doctoral work in the laboratory of Dr. Dallas Treit in Edmonton, Alberta, and was awarded a PhD Thesis Award from the Canadian...

Sabina Berretta, MD, began her research training under the mentorship of Dr. V. Perciavalle at University of Catania, Italy. In 1990, she joined the laboratory directed by Dr. A. M. Graybiel in the Department of Brain and Cognitive Sciences at MIT, working neural circuitry linking the motor cortex...

Dr. Ole Isacson is a professor of neurology at Harvard Medical School and founding director of the Neuroregeneration Research Institute at McLean Hospital. His work is focused on the understanding and treatments of neurodegenerative disease, with particular emphasis on distinguishing critical...

Penny Hallett, PhD, is an associate professor of psychiatry at Harvard Medical School and co-director of the Neuroregeneration Research Institute (NRI). She received her PhD from the University of Manchester, UK, and completed post-doctoral studies at Massachusetts General Hospital, moving in 2006...

Young Cha, PhD, received his PhD in stem cell biology from CHA University in Korea. During his PhD studies, his scientific interest was to identify novel factors which are involved in the maintenance of self-renewality and pluripotency of embryonic stem cells. He joined the Molecular Neurobiology...

Woori Kim, PhD, received her BSc, MSc, and PhD in biochemistry from Hanyang University. She joined the Molecular Neurobiology Laboratory in 2014 as a post-doctoral fellow.

Dr. Lee has worked on numerous drug discovery projects related to traditional Chinese medicine, contributing significantly to the development of alternative therapies for substance misuse and for osteoarthritis. He is the principal investigator on “Alternative Therapies for Alcohol and Drug Abuse,”...

Isabelle M. Rosso is the director of the Anxiety and Traumatic Stress Disorders Laboratory which studies neurobiological phenotypes of emotional disorders, and relates them to behavioral and clinical phenotypes. Psychiatric research has reached an exciting juncture where the neuroscience knowledge...

Dr. Lin is currently a grantee of both NIH and Fulbright, with a long-term interest in reducing the prevalence of substance abuse around the world. Dr. Lin’s research focuses on delineation of environmentally related genomic risks for substance abuse, through mapping out molecular pathways that...

Dr. Bolshakov received his PhD from the Russian Academy of Sciences in St. Petersburg and performed his post-doctoral studies at Columbia University under the mentorship of Dr. Steven Siegelbaum. He joined McLean Hospital in 1999 as an assistant professor and was promoted to full professor at...

Kerry J. Ressler, MD, PhD, is chief scientific officer and James and Patricia Poitras Chair in Psychiatry at McLean Hospital. He is also a professor in psychiatry at Harvard Medical School and past-president of the Society for Biological Psychiatry. Dr. Ressler was previously an investigator of the...

Since 2018, Torsten Klengel, MD, PhD, has been the director of the Translational Molecular Genomics Laboratory at McLean Hospital, with a secondary affiliation at the University of Goettingen, Germany. In 2014, Dr. Klengel joined the Neurobiology of Fear Laboratory, led by Kerry J. Ressler, MD, PhD...

Lauren A. M. Lebois, PhD, is a cognitive neuroscientist who is passionate about understanding how the mind, brain, and body adapt in the aftermath of trauma. She prioritizes translating scientific breakthroughs in accessible, compelling, and clinically relevant ways. Dr. Lebois’ NIMH-funded research...

Frank Tarazi, MBBS, PhD, MBA is an associate professor of Psychiatry at Harvard Medical School, and director of the Laboratory in Pharmacoeconomics and Health Outcomes at McLean Hospital. He is a preclinical and clinical expert on Alzheimer’s disease, Parkinson’s disease, schizophrenia, depression...

Rajeev I. Desai, PhD, is an assistant professor of psychiatry at Harvard Medical School and director of the Integrative Neurochemistry Laboratory at McLean Hospital. Dr. Desai received his PhD in psychology/behavioral pharmacology at the University of Birmingham, U.K. He completed post-doctoral...

Jakob Hartmann, PhD, is an assistant neuroscientist in the Neurobiology of Fear Laboratory under the mentorship of Dr. Kerry Ressler and is an assistant professor of psychiatry at Harvard Medical School. Dr. Hartmann is the recipient of several honors and fellowships, including a research...

Bin Song, PhD, works on signaling transduction and gene regulation of neuronal survival and apoptosis (programmed cell death) in service of the development of new therapeutic targets for treatment of neurodegenerative diseases such as Parkinson’s disease (PD). Dr. Song’s early research was focused...

Claudia Lopes, PhD, is interested in developing a human pluripotent stem cell-derived three-dimensional organoid culture system, to mimic distinct cerebral regions. Because organoids contain progenitor populations that develop to yield mature cortical neuron subtypes, this technology will make it...

Carol A. Paronis, PhD, is director of the Laboratory of Preclinical Pharmacology at McLean Hospital and an associate professor of psychiatry at Harvard Medical School. Dr. Paronis received her PhD in pharmacology from Emory University and completed post-doctoral fellowships in pharmacology at the...

Sivan Subburaju, PhD, is an instructor in psychiatry at Harvard Medical School and an assistant molecular neurobiologist at McLean Hospital. Dr. Subburaju’s main research focuses on translational psychiatry and neuroplastic changes associated with psychiatric disorders and stress. He has developed a...